N/A (device / behavioral)Active, not recruitingNCT07325461
Extended-wear infusion set options at home
Feasibility study of extended-wear insulin infusion set options during home use in T1D.
Primary endpoints
- 7 Day Survival of Infusion Set for Primary Outcome Measure
Results so far
No results posted yet.